
Rein Therapeutics Inc
RNTXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$1.11
Day High
$1.17
Day Low
$1.08
Prev. Close
$1.11
VolumeShares traded today.
516.81K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$94.95M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-0.63
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$2.18
52W LowLowest price over the past 52 weeks.
$0.9500
50D MAAverage closing price over the last 50 trading days.
$1.32
200D MAAverage closing price over the last 200 trading days.
$1.30
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+6.7%1M
-12.9%6M
-24.0%YTD
-11.2%1Y
-43.1%About
ALC-0315 is a synthetic lipid. A colorless oily material, it has attracted attention as a component of the SARS-CoV-2 vaccine, BNT162b2, from BioNTech and Pfizer. Specifically, it is one of four components that form lipid nanoparticles (LNPs), which encapsulate and protect the otherwise fragile mRNA that is the active ingredient in these drugs. These nanoparticles promote the uptake of therapeutically effective nucleic acids such as oligonucleotides or mRNA both in vitro and in vivo.
www.reintx.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade RNTX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.